Advanced search
Publication Cover
Future Medicinal Chemistry Volume 11, 2019 - Issue 6
Submit an article Journal homepage
4,044
Views
1
CrossRef citations to date
0
Altmetric
Review

Peeking at G-protein-coupled Receptors Through the Molecular Dynamics Keyhole

Giuseppe Deganutti1 School of Biological Sciences, University of Essex, Wivenhoe Park Colchester, CO4 3SQ, UKCorrespondence[email protected]
,
Stefano Moro2 Department of Pharmaceutical & Pharmacological Sciences, University of Padua, Via Marzolo 5, 35131, Padova, Italy
&
Christopher A Reynolds1 School of Biological Sciences, University of Essex, Wivenhoe Park Colchester, CO4 3SQ, UK
Pages 599-615 | Received 10 Aug 2018, Accepted 04 Jan 2019, Published online: 19 Mar 2019

References

  • Fredriksson R Lagerström MC Lundin L-G Schiöth HB . The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints . Mol. Pharmacol.63 ( 6 ), 1256 – 1272 ( 2003 ).
  • Kiselyov K Shin DM Muallem S . Signalling specificity in GPCR-dependent Ca2+ signalling . Cell Signal.15 ( 3 ), 243 – 253 ( 2003 ).
  • Weis WI Kobilka BK . The molecular basis of G protein-coupled receptor activation . Annu. Rev. Biochem.87 , 897 – 919 ( 2018 ).
  • Hilger D Masureel M Kobilka BK . Structure and dynamics of GPCR signaling complexes . Nat. Struct. Mol. Biol.25 ( 1 ), 4 – 12 ( 2018 ).
  • Tesmer JJG . Hitchhiking on the heptahelical highway: structure and function of 7TM receptor complexes . Nat. Rev. Mol. Cell Biol.17 ( 7 ), 439 – 450 ( 2016 ).
  • Katritch V Cherezov V Stevens RC . Structure–function of the G protein-coupled receptor superfamily . Annu. Rev. Pharmacol. Toxicol.53 , 531 – 556 ( 2013 ).
  • Kobilka BK . G protein coupled receptor structure and activation . Biochim. Biophys. Acta1768 ( 4 ), 794 – 807 ( 2007 ).
  • Hauser AS Attwood MM Rask-Andersen M Schiöth HB Gloriam DE . Trends in GPCR drug discovery: new agents, targets and indications . Nat. Rev. Drug Discov.16 ( 12 ), 829 – 842 ( 2017 ).
  • Pándy-Szekeres G Munk C Tsonkov TM et al. GPCRdb in 2018: adding GPCR structure models and ligands . Nucleic Acids Res.46 ( D1 ), D440 – D446 ( 2018 ).
  • Martínez-Rosell G Giorgino T Harvey MJ de Fabritiis G . Drug discovery and molecular dynamics: methods, applications and perspective beyond the second timescale . Curr. Top. Med. Chem.17 ( 23 ), 2617 – 2625 ( 2017 ).
  • McCammon JA Gelin BR Karplus M . Dynamics of folded proteins . Nature267 ( 5612 ), 585 – 590 ( 1977 ).
  • Shaw DE . Millisecond-long molecular dynamics simulations of proteins on a special-purpose machine . Biophys. J.104 ( 2 ), 45a ( 2013 ).
  • Deupi X Kobilka BK . Energy landscapes as a tool to integrate GPCR structure, dynamics, and function . Physiology (Bethesda)25 ( 5 ), 293 – 303 ( 2010 ).
  • Doerr S De Fabritiis G . On-the-fly learning and sampling of ligand binding by high-throughput molecular simulations . J. Chem. Theory Comput.10 ( 5 ), 2064 – 2069 ( 2014 ).
  • Bernardi RC Melo MCR Schulten K . Enhanced sampling techniques in molecular dynamics simulations of biological systems . Biochim. Biophys. Acta1850 ( 5 ), 872 – 877 ( 2015 ).
  • De Vivo M Masetti M Bottegoni G Cavalli A . Role of molecular dynamics and related methods in drug discovery . J. Med. Chem.59 ( 9 ), 4035 – 4061 ( 2016 ).
  • Deganutti G Moro S . Estimation of kinetic and thermodynamic ligand-binding parameters using computational strategies . Future Med. Chem.9 ( 5 ), 507 – 523 ( 2017 ).
  • Tummino PJ Copeland RA . Residence time of receptor-ligand complexes and its effect on biological function . Biochemistry47 ( 20 ), 5481 – 5492 ( 2008 ).
  • Copeland RA Pompliano DL Meek TD . Drug-target residence time and its implications for lead optimization . Nat. Rev. Drug Discov.5 ( 9 ), 730 – 739 ( 2006 ).
  • Dahl G Akerud T . Pharmacokinetics and the drug-target residence time concept . Drug Discov. Today18 ( 15–16 ), 697 – 707 ( 2013 ).
  • Copeland RA . The drug-target residence time model: a 10-year retrospective . Nat. Rev. Drug Discov.15 ( 2 ), 87 – 95 ( 2016 ).
  • Casarosa P Bouyssou T Germeyer S Schnapp A Gantner F Pieper M . Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs . J. Pharmacol. Exp. Ther.330 ( 2 ), 660 – 668 ( 2009 ).
  • Tautermann CS Kiechle T Seeliger D et al. Molecular basis for the long duration of action and kinetic selectivity of tiotropium for the muscarinic M3 receptor . J. Med. Chem.56 ( 21 ), 8746 – 8756 ( 2013 ).
  • Kapur S Seeman P . Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action . J. Psychiatr. Neurosci.25 ( 2 ), 161 – 166 ( 2000 ).
  • Tarsy D Baldessarini RJ . Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?Mov. Disord.21 ( 5 ), 589 – 598 ( 2006 ).
  • Soethoudt M Hoorens MWH Doelman W Martella A van der Stelt M Heitman LH . Structure–kinetic relationship studies of cannabinoid CB2 receptor agonists reveal substituent-specific lipophilic effects on residence time . Biochem. Pharmacol.152 , 129 – 142 ( 2018 ).
  • Schuetz DA de Witte WEA Wong YC et al. Kinetics for drug discovery: an industry-driven effort to target drug residence time . Drug Discov. Today22 ( 6 ), 896 – 911 ( 2017 ).
  • Guo D Heitman LH IJzerman AP . Kinetic aspects of the interaction between ligand and G protein-coupled receptor: the case of the adenosine receptors . Chem. Rev.117 ( 1 ), 38 – 66 ( 2017 ).
  • Swinney DC Haubrich BA Van Liefde I Vauquelin G . The role of binding kinetics in GPCR drug discovery . Curr. Top. Med. Chem.15 ( 24 ), 2504 – 2522 ( 2015 ).
  • Strasser A Wittmann H-J Seifert R . Binding kinetics and pathways of ligands to GPCRs . Trends Pharmacol. Sci.38 ( 8 ), 717 – 732 ( 2017 ).
  • Dror RO Pan AC Arlow DH et al. Pathway and mechanism of drug binding to G-protein-coupled receptors . Proc. Natl Acad. Sci. USA108 ( 32 ), 13118 – 13123 ( 2011 ).
  • González A Perez-Acle T Pardo L Deupi X . Molecular basis of ligand dissociation in β-adrenergic receptors . PLoS ONE6 ( 9 ), e23815 ( 2011 ).
  • Kruse AC Hu J Pan AC et al. Structure and dynamics of the M3 muscarinic acetylcholine receptor . Nature482 ( 7386 ), 552 – 556 ( 2012 ).
  • Radić Z Kirchhoff PD Quinn DM McCammon JA Taylor P . Electrostatic influence on the kinetics of ligand binding to acetylcholinesterase. Distinctions between active center ligands and fasciculin . J. Biol. Chem.272 ( 37 ), 23265 – 23277 ( 1997 ).
  • Carpenter B Lebon G . Human adenosine a2a receptor: molecular mechanism of ligand binding and activation . Front. Pharmacol.8 , 898 ( 2017 ).
  • Guo D Pan AC Dror RO et al. Molecular basis of ligand dissociation from the adenosine A2A receptor . Mol. Pharmacol.89 ( 5 ), 485 – 491 ( 2016 ).
  • Segala E Guo D Cheng RKY et al. Controlling the dissociation of ligands from the adenosine A2A receptor through modulation of salt bridge strength . J. Med. Chem.59 ( 13 ), 6470 – 6479 ( 2016 ).
  • Sabbadin D Ciancetta A Deganutti G Cuzzolin A Moro S . Exploring the recognition pathway at the human A2A adenosine receptor of the endogenous agonist adenosine using supervised molecular dynamics simulations . Medchemcomm6 ( 6 ), 1081 – 1085 ( 2015 ).
  • Deganutti G Welihinda A Moro S . Comparison of the human A2A adenosine receptor recognition by adenosine and inosine: new insight from supervised molecular dynamics simulations . ChemMedChem.12 ( 16 ), 1319 – 1326 ( 2017 ).
  • Sabbadin D Moro S . Supervised molecular dynamics (SuMD) as a helpful tool to depict GPCR-ligand recognition pathway in a nanosecond time scale . J. Chem. Inf. Model.54 ( 2 ), 372 – 376 ( 2014 ).
  • Cuzzolin A Sturlese M Deganutti G et al. Deciphering the complexity of ligand–protein recognition pathways using supervised molecular dynamics (SuMD) simulations . J. Chem. Inf. Model.56 ( 4 ), 687 – 705 ( 2016 ).
  • Christopoulos A Kenakin T . G protein-coupled receptor allosterism and complexing . Pharmacol. Rev.54 ( 2 ), 323 – 374 ( 2002 ).
  • DeVree BT Mahoney JP Vélez-Ruiz GA et al. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs . Nature535 ( 7610 ), 182 – 186 ( 2016 ).
  • Deganutti G Salmaso V Moro S . Could adenosine recognize its receptors with a stoichiometry other than 1:1?Mol. Inform.37 ( 8 ), e1800009 ( 2018 ).
  • Igonet S Raingeval C Cecon E et al. Enabling STD-NMR fragment screening using stabilized native GPCR: a case study of adenosine receptor . Sci. Rep.8 ( 1 ), 8142 ( 2018 ).
  • Deganutti G Zhukov A Deflorian F et al. Impact of protein–ligand solvation and desolvation on transition state thermodynamic properties of adenosine A2A ligand binding kinetics . In Silico Pharmacol.5 ( 1 ), 16 ( 2016 ).
  • Yuan X Raniolo S Limongelli V Xu Y . The molecular mechanism underlying ligand binding to the membrane-embedded site of a G-protein-coupled receptor . J. Chem. Theory Comput.14 ( 5 ), 2761 – 2770 ( 2018 ).
  • Hurst DP Grossfield A Lynch DL et al. A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptor . J. Biol. Chem.285 ( 23 ), 17954 – 17964 ( 2010 ).
  • Stanley N Pardo L Fabritiis GD . The pathway of ligand entry from the membrane bilayer to a lipid G protein-coupled receptor . Sci. Rep.6 , 22639 ( 2016 ).
  • Bokoch MP Jo HI Valcourt JR et al. Entry from the lipid bilayer: a novel pathway for inhibition of a peptide G-protein coupled receptor by a lipophilic small molecule . Biophys. J.108 ( 2 ), 350a ( 2015 ).
  • Bokoch MP Jo H Valcourt JR et al. Entry from the lipid bilayer: a possible pathway for inhibition of a peptide G protein-coupled receptor by a lipophilic small molecule . Biochemistry57 ( 39 ), 5748 – 5758 ( 2018 ).
  • Bruce NJ Ganotra GK Kokh DB Sadiq SK Wade RC . New approaches for computing ligand-receptor binding kinetics . Curr. Opin. Struct. Biol.49 , 1 – 10 ( 2018 ).
  • Pande VS Beauchamp K Bowman GR . Everything you wanted to know about Markov state models but were afraid to ask . Methods52 ( 1 ), 99 – 105 ( 2010 ).
  • Plattner N Doerr S De Fabritiis G Noé F . Complete protein–protein association kinetics in atomic detail revealed by molecular dynamics simulations and Markov modelling . Nat. Chem.9 ( 10 ), 1005 – 1011 ( 2017 ).
  • Paul F Wehmeyer C Abualrous ET et al. Protein-peptide association kinetics beyond the seconds timescale from atomistic simulations . Nat. Commun.8 ( 1 ), 1095 ( 2017 ).
  • Bortolato A Deflorian F Weiss DR Mason JS . Decoding the role of water dynamics in ligand–protein unbinding: CRF1R as a test case . J. Chem. Inf. Model.55 ( 9 ), 1857 – 1866 ( 2015 ).
  • Doré AS Bortolato A Hollenstein K Cheng RKY Read RJ Marshall FH . Decoding corticotropin-releasing factor receptor type 1 crystal structures . Curr. Mol. Pharmacol.10 ( 4 ), 334 – 344 ( 2017 ).
  • Rosenbaum DM Rasmussen SGF Kobilka BK . The structure and function of G-protein-coupled receptors . Nature459 ( 7245 ), 356 – 363 ( 2009 ).
  • Pierce KL Premont RT Lefkowitz RJ . Seven-transmembrane receptors . Nat. Rev. Mol. Cell Biol.3 ( 9 ), 639 – 650 ( 2002 ).
  • De Lean A Stadel JM Lefkowitz RJ . A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor . J. Biol. Chem.255 ( 15 ), 7108 – 7117 ( 1980 ).
  • Kobilka BK Deupi X . Conformational complexity of G-protein-coupled receptors . Trends Pharmacol. Sci.28 ( 8 ), 397 – 406 ( 2007 ).
  • Latorraca NR Venkatakrishnan AJ Dror RO . GPCR dynamics: structures in motion . Chem. Rev.117 ( 1 ), 139 – 155 ( 2017 ).
  • Venkatakrishnan AJ Deupi X Lebon G Tate CG Schertler GF Babu MM . Molecular signatures of G-protein-coupled receptors . Nature494 ( 7436 ), 185 – 194 ( 2013 ).
  • de Graaf C Song G Cao C et al. Extending the structural view of class B GPCRs . Trends Biochem. Sci.42 ( 12 ), 946 – 960 ( 2017 ).
  • Venkatakrishnan AJ Deupi X Lebon G et al. Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region . Nature536 ( 7617 ), 484 – 487 ( 2016 ).
  • Isberg V Mordalski S Munk C et al. GPCRdb: an information system for G protein-coupled receptors . Nucleic Acids Res.44 ( D1 ), D356 – D364 ( 2016 ).
  • Dror RO Arlow DH Maragakis P et al. Activation mechanism of the β2-adrenergic receptor . Proc. Natl. Acad. Sci. USA108 ( 46 ), 18684 – 18689 ( 2011 ).
  • Rasmussen SGF DeVree BT Zou Y et al. Crystal structure of the β2 adrenergic receptor-Gs protein complex . Nature477 ( 7366 ), 549 – 555 ( 2011 ).
  • Rasmussen SGF Choi H-J Fung JJ et al. Structure of a nanobody-stabilized active state of the β(2) adrenoceptor . Nature469 ( 7329 ), 175 – 180 ( 2011 ).
  • Ghanouni P Gryczynski Z Steenhuis JJ et al. Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor . J. Biol. Chem.276 ( 27 ), 24433 – 24436 ( 2001 ).
  • Huang W Manglik A Venkatakrishnan AJ et al. Structural insights into μ-opioid receptor activation . Nature524 ( 7565 ), 315 – 321 ( 2015 ).
  • Sena DM Cong X Giorgetti A Kless A Carloni P . Structural heterogeneity of the μ-opioid receptor's conformational ensemble in the apo state . Sci. Rep.8 , 45761 ( 2017 ).
  • Nygaard R Zou Y Dror RO et al. The dynamic process of β(2)-adrenergic receptor activation . Cell152 ( 3 ), 532 – 542 ( 2013 ).
  • Kohlhoff KJ Shukla D Lawrenz M et al. Cloud-based simulations on Google Exacycle reveal ligand modulation of GPCR activation pathways . Nat. Chem.6 ( 1 ), 15 – 21 ( 2014 ).
  • Li J Jonsson AL Beuming T Shelley JC Voth GA . Ligand-dependent activation and deactivation of the human adenosine A(2A) receptor . J. Am. Chem. Soc.135 ( 23 ), 8749 – 8759 ( 2013 ).
  • Lee Y Choi S Hyeon C . Communication over the network of binary switches regulates the activation of A2A adenosine receptor . PLoS Comput. Biol.11 ( 2 ), e1004044 ( 2015 ).
  • Miao Y Nichols SE Gasper PM Metzger VT McCammon JA . Activation and dynamic network of the M2 muscarinic receptor . Proc. Natl Acad. Sci. USA110 ( 27 ), 10982 – 10987 ( 2013 ).
  • Jiménez-Rosés M Matsoukas M-T Caltabiano G Cordomí A . Ligand-triggered structural changes in the M2 muscarinic acetylcholine receptor . J. Chem. Inf. Model.58 ( 5 ), 1074 – 1082 ( 2018 ).
  • Kruse AC Ring AM Manglik A et al. Activation and allosteric modulation of a muscarinic acetylcholine receptor . Nature504 ( 7478 ), 101 – 106 ( 2013 ).
  • Pupo AS Duarte DA Lima V Teixeira LB Parreiras-E-Silva LT Costa-Neto CM . Recent updates on GPCR biased agonism . Pharmacol. Res.112 , 49 – 57 ( 2016 ).
  • Shukla AK Singh G Ghosh E . Emerging structural insights into biased GPCR signaling . Trends Biochem. Sci.39 ( 12 ), 594 – 602 ( 2014 ).
  • Smith JS Lefkowitz RJ Rajagopal S . Biased signalling: from simple switches to allosteric microprocessors . Nat. Rev. Drug Discov.17 ( 4 ), 243 – 260 ( 2018 ).
  • Liang Y-L Khoshouei M Glukhova A et al. Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex . Nature555 ( 7694 ), 121 – 125 ( 2018 ).
  • Violin JD Crombie AL Soergel DG Lark MW . Biased ligands at G-protein-coupled receptors: promise and progress . Trends Pharmacol. Sci.35 ( 7 ), 308 – 316 ( 2014 ).
  • Klein Herenbrink C Sykes DA Donthamsetti P et al. The role of kinetic context in apparent biased agonism at GPCRs . Nat. Commun.7 , 10842 ( 2016 ).
  • Grundmann M Kostenis E . Temporal bias: time-encoded dynamic GPCR signaling . Trends Pharmacol. Sci.38 ( 12 ), 1110 – 1124 ( 2017 ).
  • Schneider S Provasi D Filizola M . How oliceridine (TRV-130) binds and stabilizes a μ-opioid receptor conformational state that selectively triggers G protein signaling pathways . Biochemistry55 ( 46 ), 6456 – 6466 ( 2016 ).
  • Singla N Minkowitz HS Soergel DG et al. A randomized, Phase IIb study investigating oliceridine (TRV130), a novel μ-receptor G-protein pathway selective (μ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty . J. Pain Res.10 , 2413 – 2424 ( 2017 ).
  • Miao Y McCammon JA . Mechanism of the G-protein mimetic nanobody binding to a muscarinic G-protein-coupled receptor . Proc. Natl Acad. Sci. USA115 ( 12 ), 3036 – 3041 ( 2018 ).
  • Eichel K Jullié D Barsi-Rhyne B et al. Catalytic activation of β-arrestin by GPCRs . Nature557 ( 7705 ), 381 – 386 ( 2018 ).
  • Latorraca NR Wang JK Bauer B et al. Molecular mechanism of GPCR-mediated arrestin activation . Nature557 ( 7705 ), 452 – 456 ( 2018 ).
  • Ballesteros JA Weinstein H . Integrated methods for the construction of three-dimensional models and computational probing of structure–function relations in G protein-coupled receptors . Methods Neurosci.25 , 366 – 428 ( 1995 ).
  • Thal DM Glukhova A Sexton PM Christopoulos A . Structural insights into G-protein-coupled receptor allostery . Nature559 ( 7712 ), 45 – 53 ( 2018 ).
  • van der Westhuizen ET Valant C Sexton PM Christopoulos A . Endogenous allosteric modulators of G protein-coupled receptors . J. Pharmacol. Exp. Ther.353 ( 2 ), 246 – 260 ( 2015 ).
  • Wootten D Christopoulos A Sexton PM . Emerging paradigms in GPCR allostery: implications for drug discovery . Nat. Rev. Drug Discov.12 ( 8 ), 630 – 644 ( 2013 ).
  • Katritch V Fenalti G Abola EE Roth BL Cherezov V Stevens RC . Allosteric sodium in class A GPCR signaling . Trends Biochem. Sci.39 ( 5 ), 233 – 244 ( 2014 ).
  • Liu W Chun E Thompson AA et al. Structural basis for allosteric regulation of GPCRs by sodium ions . Science337 ( 6091 ), 232 – 236 ( 2012 ).
  • Selent J Sanz F Pastor M De Fabritiis G . Induced effects of sodium ions on dopaminergic G-protein coupled receptors . PLoS Comput. Biol.6 ( 8 ), e1000884 ( 2010 ).
  • Miao Y Caliman AD McCammon JA . Allosteric effects of sodium ion binding on activation of the m3 muscarinic g-protein-coupled receptor . Biophys. J.108 ( 7 ), 1796 – 1806 ( 2015 ).
  • Yuan S Vogel H Filipek S . The role of water and sodium ions in the activation of the μ-opioid receptor . Angew. Chem. Int. Ed. Engl.52 ( 38 ), 10112 – 10115 ( 2013 ).
  • Gutiérrez-de-Terán H Massink A Rodríguez D et al. The role of a sodium ion binding site in the allosteric modulation of the A(2A) adenosine G protein-coupled receptor . Structure21 ( 12 ), 2175 – 2185 ( 2013 ).
  • Bartuzi D Kaczor AA Matosiuk D . Interplay between two allosteric sites and their influence on agonist binding in human μ opioid receptor . J. Chem. Inf. Model.56 ( 3 ), 563 – 570 ( 2016 ).
  • Massink A Gutiérrez-de-Terán H Lenselink EB et al. Sodium ion binding pocket mutations and adenosine A2A receptor function . Mol. Pharmacol.87 ( 2 ), 305 – 313 ( 2015 ).
  • Shang Y LeRouzic V Schneider S Bisignano P Pasternak GW Filizola M . Mechanistic insights into the allosteric modulation of opioid receptors by sodium ions . Biochemistry53 ( 31 ), 5140 – 5149 ( 2014 ).
  • Selvam B Shamsi Z Shukla D . Universality of the sodium ion binding mechanism in class A G-protein-coupled receptors . Angew. Chem. Int. Ed. Engl.57 ( 12 ), 3048 – 3053 ( 2018 ).
  • Vohra S Taddese B Conner AC et al. Similarity between class A and class B G-protein-coupled receptors exemplified through calcitonin gene-related peptide receptor modelling and mutagenesis studies . J. R. Soc. Interface.10 ( 79 ), 20120846 ( 2013 ).
  • Pasternak GW Snowman AM Snyder SH . Selective enhancement of [3H]opiate agonist binding by divalent cations . Mol. Pharmacol.11 ( 6 ), 735 – 744 ( 1975 ).
  • Burgmer U Schulz U Tränkle C Mohr K . Interaction of Mg2+ with the allosteric site of muscarinic M2 receptors . Naunyn Schmiedebergs Arch. Pharmacol.357 ( 4 ), 363 – 370 ( 1998 ).
  • Johansson B Parkinson FE Fredholm BB . Effects of mono- and divalent ions on the binding of the adenosine analogue CGS 21680 to adenosine A2 receptors in rat striatum . Biochem. Pharmacol.44 ( 12 ), 2365 – 2370 ( 1992 ).
  • Mazzoni MR Martini C Lucacchini A . Regulation of agonist binding to A2A adenosine receptors: effects of guanine nucleotides (GDP[S] and GTP[S]) and Mg2+ ion . Biochim. Biophys. Acta1220 ( 1 ), 76 – 84 ( 1993 ).
  • Ye L Neale C Sljoka A et al. Mechanistic insights into allosteric regulation of the A2A adenosine G protein-coupled receptor by physiological cations . Nat. Commun.9 ( 1 ), 1372 ( 2018 ).
  • Gentry PR Sexton PM Christopoulos A . Novel allosteric modulators of G protein-coupled receptors . J. Biol. Chem.290 ( 32 ), 19478 – 19488 ( 2015 ).
  • Aurelio L Valant C Flynn BL Sexton PM Christopoulos A Scammells PJ . Allosteric modulators of the adenosine A1 receptor: synthesis and pharmacological evaluation of 4-substituted 2-amino-3-benzoylthiophenes . J. Med. Chem.52 ( 14 ), 4543 – 4547 ( 2009 ).
  • Dror RO Green HF Valant C et al. Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs . Nature503 ( 7475 ), 295 – 299 ( 2013 ).
  • Shang Y Yeatman HR Provasi D et al. Proposed mode of binding and action of positive allosteric modulators at opioid receptors . ACS Chem. Biol.11 ( 5 ), 1220 – 1229 ( 2016 ).
  • Deganutti G Cuzzolin A Ciancetta A Moro S . Understanding allosteric interactions in G protein-coupled receptors using supervised molecular dynamics: a prototype study analysing the human A3 adenosine receptor positive allosteric modulator LUF6000 . Bioorg. Med. Chem.23 ( 14 ), 4065 – 4071 ( 2015 ).
  • Saleh N Hucke O Montel F et al. Multiple binding sites contribute to the mechanism of mixed agonistic and positive allosteric modulators of the Cannabinoid CB1 receptor . Angew. Chem. Int. Ed. Engl.57 ( 10 ), 2580 – 2585 ( 2018 ).
  • Vaidehi N Bhattacharya S . Allosteric communication pipelines in G-protein-coupled receptors . Curr. Opin. Pharmacol.30 , 76 – 83 ( 2016 ).
  • Pandini A Fornili A Fraternali F Kleinjung J . Detection of allosteric signal transmission by information-theoretic analysis of protein dynamics . FASEB J.26 ( 2 ), 868 – 881 ( 2012 ).
  • Rivalta I Sultan MM Lee N-S Manley GA Loria JP Batista VS . Allosteric pathways in imidazole glycerol phosphate synthase . Proc. Natl Acad. Sci. USA109 ( 22 ), E1428 – E1436 ( 2012 ).
  • McClendon CL Friedland G Mobley DL Amirkhani H Jacobson MP . Quantifying correlations between allosteric sites in thermodynamic ensembles . J. Chem. Theory Comput.5 ( 9 ), 2486 – 2502 ( 2009 ).
  • Bhattacharya S Vaidehi N . Differences in allosteric communication pipelines in the inactive and active states of a GPCR . Biophys. J.107 ( 2 ), 422 – 434 ( 2014 ).
  • La Sala G Decherchi S De Vivo M Rocchia W . Allosteric communication networks in proteins revealed through pocket crosstalk analysis . ACS Cent. Sci.3 ( 9 ), 949 – 960 ( 2017 ).
  • Venkatakrishnan AJ Ma A Fonseca R et al. Stable networks of water-mediated interactions are conserved in activation of diverse GPCRs . BioRxiv ( 2018 ). www.biorxiv.org/content/biorxiv/early/2018/06/20/351502.full.pdf
  • Yuan S Palczewski K Peng Q Kolinski M Vogel H Filipek S . The mechanism of ligand-induced activation or inhibition of μ- and κ-opioid receptors . Angew. Chem. Int. Ed. Engl.54 ( 26 ), 7560 – 7563 ( 2015 ).
  • Yuan S Filipek S Palczewski K Vogel H . Activation of G-protein-coupled receptors correlates with the formation of a continuous internal water pathway . Nat. Commun.5 , 4733 ( 2014 ).
  • Lee Y Kim S Choi S Hyeon C . Ultraslow water-mediated transmembrane interactions regulate the activation of A2A adenosine receptor . Biophys. J.111 ( 6 ), 1180 – 1191 ( 2016 ).
  • Abel R Young T Farid R Berne BJ Friesner RA . Role of the active-site solvent in the thermodynamics of factor Xa ligand binding . J. Am. Chem. Soc.130 ( 9 ), 2817 – 2831 ( 2008 ).
  • Ramsey S Nguyen C Salomon-Ferrer R Walker RC Gilson MK Kurtzman T . Solvation thermodynamic mapping of molecular surfaces in AmberTools: GIST . J. Comput. Chem.37 ( 21 ), 2029 – 2037 ( 2016 ).
  • López ED Arcon JP Gauto DF et al. WATCLUST: a tool for improving the design of drugs based on protein–water interactions . Bioinformatics31 ( 22 ), 3697 – 3699 ( 2015 ).
  • Hu B Lill MA . WATsite: hydration site prediction program with PyMOL interface . J. Comput. Chem.35 ( 16 ), 1255 – 1260 ( 2014 ).
  • Cuzzolin A Deganutti G Salmaso V Sturlese M Moro S . AquaMMapS: an alternative tool to monitor the role of water molecules during protein–ligand association . ChemMedChem.13 ( 6 ), 522 – 531 ( 2018 ).
  • Zia SR Gaspari R Decherchi S Rocchia W . Probing hydration patterns in class-A GPCRs via biased MD: the A2A receptor . J. Chem. Theory Comput.12 ( 12 ), 6049 – 6061 ( 2016 ).
  • Higgs C Beuming T Sherman W . Hydration site thermodynamics explain SARs for triazolylpurines analogues binding to the A2A receptor . ACS Med. Chem. Lett.1 ( 4 ), 160 – 164 ( 2010 ).
  • Bortolato A Tehan BG Bodnarchuk MS Essex JW Mason JS . Water network perturbation in ligand binding: adenosine A(2A) antagonists as a case study . J. Chem. Inf. Model.53 ( 7 ), 1700 – 1713 ( 2013 ).
  • Hedger G Sansom MSP . Lipid interaction sites on channels, transporters and receptors: recent insights from molecular dynamics simulations . Biochim. Biophys. Acta.1858 ( 10 ), 2390 – 2400 ( 2016 ).
  • Escribá PV Wedegaertner PB Goñi FM Vögler O . Lipid–protein interactions in GPCR-associated signaling . Biochim. Biophys. Acta.1768 ( 4 ), 836 – 852 ( 2007 ).
  • Mondal S Khelashvili G Weinstein H . Not just an oil slick: how the energetics of protein–membrane interactions impacts the function and organization of transmembrane proteins . Biophys. J.106 ( 11 ), 2305 – 2316 ( 2014 ).
  • Grossfield A Feller SE Pitman MC . A role for direct interactions in the modulation of rhodopsin by omega-3 polyunsaturated lipids . Proc. Natl Acad. Sci. USA103 ( 13 ), 4888 – 4893 ( 2006 ).
  • Salas-Estrada LA Leioatts N Romo TD Grossfield A . Lipids alter rhodopsin function via ligand-like and solvent-like interactions . Biophys. J.114 ( 2 ), 355 – 367 ( 2018 ).
  • Khelashvili G Grossfield A Feller SE Pitman MC Weinstein H . Structural and dynamic effects of cholesterol at preferred sites of interaction with rhodopsin identified from microsecond length molecular dynamics simulations . Proteins76 ( 2 ), 403 – 417 ( 2009 ).
  • Cang X Du Y Mao Y Wang Y Yang H Jiang H . Mapping the functional binding sites of cholesterol in β2-adrenergic receptor by long-time molecular dynamics simulations . J. Phys. Chem. B.117 ( 4 ), 1085 – 1094 ( 2013 ).
  • Terrillon S Bouvier M . Roles of G-protein-coupled receptor dimerization . EMBO Rep.5 ( 1 ), 30 – 34 ( 2004 ).
  • Milligan G . G protein-coupled receptor dimerisation: molecular basis and relevance to function . Biochim. Biophys. Acta1768 ( 4 ), 825 – 835 ( 2007 ).
  • Shan J Khelashvili G Mondal S Mehler EL Weinstein H . Ligand-dependent conformations and dynamics of the serotonin 5-HT(2A) receptor determine its activation and membrane-driven oligomerization properties . PLoS Comput. Biol.8 ( 4 ), e1002473 ( 2012 ).
  • Lee JY Lyman E . Predictions for cholesterol interaction sites on the A2A adenosine receptor . J. Am. Chem. Soc.134 ( 40 ), 16512 – 16515 ( 2012 ).
  • Neale C Herce HD Pomès R García AE . Can specific protein-lipid interactions stabilize an active state of the beta 2 adrenergic receptor?Biophys. J.109 ( 8 ), 1652 – 1662 ( 2015 ).
  • Bruzzese A Gil C Dalton JAR Giraldo J . Structural insights into positive and negative allosteric regulation of a G protein-coupled receptor through protein–lipid interactions . Sci. Rep.8 ( 1 ), 4456 ( 2018 ).
  • Yen H-Y Hoi KK Liko I et al. PtdIns(4,5)P2 stabilizes active states of GPCRs and enhances selectivity of G-protein coupling . Nature559 ( 7714 ), 423 – 427 ( 2018 ).
  • Liang Y-L Khoshouei M Deganutti G et al. Cryo-EM structure of the active, Gs-protein complexed, human CGRP receptor . Nature561 , 492 – 497 ( 2018 ).
  • Hoare SRJ . Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors . Drug Discov. Today10 ( 6 ), 417 – 427 ( 2005 ).
  • Hollenstein K de Graaf C Bortolato A Wang M-W Marshall FH Stevens RC . Insights into the structure of class B GPCRs . Trends Pharmacol. Sci.35 ( 1 ), 12 – 22 ( 2014 ).
  • Bortolato A Doré AS Hollenstein K Tehan BG Mason JS Marshall FH . Structure of class B GPCRs: new horizons for drug discovery . Br. J. Pharmacol.171 ( 13 ), 3132 – 3145 ( 2014 ).
  • Wootten D Miller LJ Koole C Christopoulos A Sexton PM . Allostery and biased agonism at class B G protein-coupled receptors . Chem. Rev.117 ( 1 ), 111 – 138 ( 2017 ).
  • Yang L Yang D de Graaf C et al. Conformational states of the full-length glucagon receptor . Nat. Commun.6 , 7859 ( 2015 ).
  • Woolley MJ Reynolds CA Simms J et al. Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs . Biochem. Pharmacol.142 , 96 – 110 ( 2017 ).
  • Bower RL Yule L Rees TA et al. Molecular signature for receptor engagement in the metabolic peptide hormone amylin . ACS Pharmacol. Transl. Sci.1 , 32 – 49 ( 2018 ).
  • Wootten D Reynolds CA Smith KJ et al. Key interactions by conserved polar amino acids located at the transmembrane helical boundaries in Class B GPCRs modulate activation, effector specificity and biased signalling in the glucagon-like peptide-1 receptor . Biochem. Pharmacol.118 , 68 – 87 ( 2016 ).
  • Wootten D Reynolds CA Koole C et al. A hydrogen-bonded polar network in the core of the glucagon-like peptide-1 receptor is a fulcrum for biased agonism: lessons from class B crystal structures . Mol. Pharmacol.89 ( 3 ), 335 – 347 ( 2016 ).
  • Wootten D Reynolds CA Smith KJ et al. The extracellular surface of the GLP-1 receptor is a molecular trigger for biased agonism . Cell165 ( 7 ), 1632 – 1643 ( 2016 ).
  • Dal Maso E Zhu Y Pham V et al. Extracellular loops 2 and 3 of the calcitonin receptor selectively modify agonist binding and efficacy . Biochem. Pharmacol.150 , 214 – 244 ( 2018 ).
  • Weaver RE Mobarec JC Wigglesworth MJ Reynolds CA Donnelly D . High affinity binding of the peptide agonist TIP-39 to the parathyroid hormone 2 (PTH2) receptor requires the hydroxyl group of Tyr-318 on transmembrane helix 5 . Biochem. Pharmacol.127 , 71 – 81 ( 2017 ).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.